ELGEKA S.A. would like to notify the investing public that its subsidiary, ELGEKA (CYPRUS) LTD, sold its participation percentage in MEDIZONE GERMANY GMBH for euro 170.000,00 (before taxes and transfer expenses). The participation percentage was 27,50% while the company was consolidated using the equity method.
MEDIZONE GERMANY GMBH, has its headquarters in Munich and provides services in the pharmaceutical sector (intermediation of exports).